Andere Sprachen Guobang Pharma Ltd.

Aktien

605507

CNE100004NS2

605507

Pharmazeutika

Schlusskurs Shanghai S.E. Andere Börsenplätze 16.06.2025			% 5 Tage	% 1. Jan.
20.28 ^CNY	-0.49%		-0.54%	-2.64%

15.04.	Guobang Pharma Ltd. meldet Gewinn für das erste Quartal zum 31. März 2025	CI
27.03.	Guobang Pharma Ltd. meldet die Ergebnisse für das Geschäftsjahr bis zum 31. Dezember 2024	CI

Andere Sprachen

Guobang Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025	15.04.
Tranche Update on Guobang Pharma Ltd.'s Equity Buyback Plan announced on March 11, 2025.	02.04.
Guobang Pharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024	27.03.
Guobang Pharma Ltd. announces Annual dividend, payable on June 13, 2025	27.03.
Guobang Pharma Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	11.03.
Guobang Pharma Ltd. authorizes a Buyback Plan.	10.03.
Guobang Pharma Subsidiary Gains Approval for Domestic Production of Cefuroxime Axetil API	28.02.
Guobang Pharma Ltd.'s Equity Buyback announced on January 27, 2024, has closed with 6,585,300 shares, representing 1.18% for CNY 108.04 million	25.01.
Tranche Update on Guobang Pharma Ltd.'s Equity Buyback Plan announced on January 27, 2024.	25.01.
Tranche Update on Guobang Pharma Ltd.'s Equity Buyback Plan announced on January 27, 2024.	03.01.
Guobang Pharma Unit's Florfenicol Production Passes US FDA Inspection	20.12.
Guobang Pharma's Q3 Profit Rises 32%	21.10.24
Guobang Pharma Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024	18.10.24
Tranche Update on Guobang Pharma Ltd.'s Equity Buyback Plan announced on January 27, 2024.	09.10.24
Guobang Pharma Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024	29.08.24
Tranche Update on Guobang Pharma Ltd.'s Equity Buyback Plan announced on January 27, 2024.	02.07.24
Guobang Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	15.04.24
Guobang Pharma Ltd. announces an Equity Buyback for CNY 200 million worth of its shares.	27.01.24
Guobang Pharma Ltd. authorizes a Buyback Plan.	26.01.24
Hangzhou Shenshi Energy Conservation Technology Co.,Ltd announced that it has received CNY 200 million in funding from Zhejiang Yinxinggu Investment Co, Ltd., Guobang Pharma Ltd., Beiqi Foton Motor Co.,Ltd., China V Fund Management Co., Ltd., Gold Stone Investment Co., Ltd. and other investors.	20.11.23
Guobang Pharma Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	18.10.23
Guobang Pharma Ltd.(XSSC:605507) added to S&P Global BMI Index	18.09.23
Guobang Pharma Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	27.07.23
Guobang Pharma Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	14.04.23
Guobang Pharma Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	09.04.23

Keine Ergebnisse zu dieser Suche

Mehr Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Guobang Pharma Ltd.

Aktien

605507

CNE100004NS2

605507

Pharmazeutika

Andere Sprachen

Filter